UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, vol.19, no.4, pp.182-185, 2020 (ESCI)
Objective: Bacillus Calmette-Guerin (BCG) limited availability, cost, and allergic response in some patients limit its use, leading to the search for alternative agents. We aimed to present the outcomes of intermediate- and high-risk non-muscle invasive bladder cancers treated with bladder wall thermochemotherapy (BWT) system via a single-arm prospective study.